Dianthus Therapeutics Stock Market Value
| DNTH Stock | 53.39 0.03 0.06% |
| Symbol | Dianthus |
Is there potential for Biotechnology market expansion? Will Dianthus introduce new products? Factors like these will boost the valuation of Dianthus Therapeutics. Projected growth potential of Dianthus fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Dianthus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.50) | Revenue Per Share | Quarterly Revenue Growth (0.82) | Return On Assets | Return On Equity |
The market value of Dianthus Therapeutics is measured differently than its book value, which is the value of Dianthus that is recorded on the company's balance sheet. Investors also form their own opinion of Dianthus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dianthus Therapeutics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Dianthus Therapeutics' market value can be influenced by many factors that don't directly affect Dianthus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Dianthus Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Dianthus Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Dianthus Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Dianthus Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dianthus Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dianthus Therapeutics.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in Dianthus Therapeutics on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding Dianthus Therapeutics or generate 0.0% return on investment in Dianthus Therapeutics over 90 days. Dianthus Therapeutics is related to or competes with Enliven Therapeutics, Taysha Gene, Sana Biotechnology, ATAI Life, Nektar Therapeutics, AnaptysBio, and Oculis Holding. Dianthus Therapeutics is entity of United States More
Dianthus Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dianthus Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dianthus Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.87 | |||
| Information Ratio | 0.1831 | |||
| Maximum Drawdown | 22.1 | |||
| Value At Risk | (4.47) | |||
| Potential Upside | 8.0 |
Dianthus Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dianthus Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dianthus Therapeutics' standard deviation. In reality, there are many statistical measures that can use Dianthus Therapeutics historical prices to predict the future Dianthus Therapeutics' volatility.| Risk Adjusted Performance | 0.1487 | |||
| Jensen Alpha | 0.7959 | |||
| Total Risk Alpha | 0.5799 | |||
| Sortino Ratio | 0.258 | |||
| Treynor Ratio | (1.31) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dianthus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Dianthus Therapeutics February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1487 | |||
| Market Risk Adjusted Performance | (1.30) | |||
| Mean Deviation | 2.74 | |||
| Semi Deviation | 2.25 | |||
| Downside Deviation | 2.87 | |||
| Coefficient Of Variation | 514.85 | |||
| Standard Deviation | 4.04 | |||
| Variance | 16.34 | |||
| Information Ratio | 0.1831 | |||
| Jensen Alpha | 0.7959 | |||
| Total Risk Alpha | 0.5799 | |||
| Sortino Ratio | 0.258 | |||
| Treynor Ratio | (1.31) | |||
| Maximum Drawdown | 22.1 | |||
| Value At Risk | (4.47) | |||
| Potential Upside | 8.0 | |||
| Downside Variance | 8.23 | |||
| Semi Variance | 5.06 | |||
| Expected Short fall | (3.31) | |||
| Skewness | 1.32 | |||
| Kurtosis | 3.57 |
Dianthus Therapeutics Backtested Returns
Dianthus Therapeutics appears to be very steady, given 3 months investment horizon. Dianthus Therapeutics secures Sharpe Ratio (or Efficiency) of 0.21, which denotes the company had a 0.21 % return per unit of standard deviation over the last 3 months. By reviewing Dianthus Therapeutics' technical indicators, you can evaluate if the expected return of 0.86% is justified by implied risk. Please utilize Dianthus Therapeutics' Downside Deviation of 2.87, mean deviation of 2.74, and Semi Deviation of 2.25 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Dianthus Therapeutics holds a performance score of 16. The firm shows a Beta (market volatility) of -0.59, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Dianthus Therapeutics are expected to decrease at a much lower rate. During the bear market, Dianthus Therapeutics is likely to outperform the market. Please check Dianthus Therapeutics' coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Dianthus Therapeutics' price patterns will revert.
Auto-correlation | 0.42 |
Average predictability
Dianthus Therapeutics has average predictability. Overlapping area represents the amount of predictability between Dianthus Therapeutics time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dianthus Therapeutics price movement. The serial correlation of 0.42 indicates that just about 42.0% of current Dianthus Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.42 | |
| Spearman Rank Test | 0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 29.3 |
Currently Active Assets on Macroaxis
| VGIAX | Vanguard Growth And | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| ASML | ASML Holding NV |
Check out Dianthus Therapeutics Correlation, Dianthus Therapeutics Volatility and Dianthus Therapeutics Performance module to complement your research on Dianthus Therapeutics. For more detail on how to invest in Dianthus Stock please use our How to Invest in Dianthus Therapeutics guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Dianthus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.